These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 1357221)

  • 1. [Role of urapidil in the treatment of arterial hypertension].
    Ol'binskaia LI; Vertkin AL; Gogin EE; Zadionchenko VS; Martynov AI; Martynov IV; Kolassa N; Man int Vel'd AI; Sidorenko BA; Belova EV
    Kardiologiia; 1992 Apr; 32(4):99-111. PubMed ID: 1357221
    [No Abstract]   [Full Text] [Related]  

  • 2. Antihypertensive therapy with adrenergic beta-receptor blockers and vasodilators.
    Aenishänslin W; Pestalozzi-Kerpel J; Dubach UC; Imhof PR; Turri M
    Eur J Clin Pharmacol; 1972 Jun; 4(3):177-81. PubMed ID: 4144064
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effect of nebivolol on remodeling of the heart and vessels and the state of hemodynamics in patients with hypertension].
    Gromnatskiĭ NI; Dius'mikeeva NB
    Kardiologiia; 2002; 42(10):27-30. PubMed ID: 12494053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological basis for combination therapy of hypertension.
    Dolley CT
    Annu Rev Pharmacol Toxicol; 1977; 17():311-23. PubMed ID: 17355
    [No Abstract]   [Full Text] [Related]  

  • 5. Influence of salt intake on the antihypertensive effect of carvedilol.
    Ruilope LM; Lahera V
    J Hypertens Suppl; 1993 Jun; 11(4):S17-9. PubMed ID: 8104238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Practical clinical pharmacology of antihypertensive drugs.
    Gifford RW
    Cardiovasc Clin; 1975; 7(1):143-56. PubMed ID: 238740
    [No Abstract]   [Full Text] [Related]  

  • 7. [The treatment of intraoperative arterial hypertension with Urapidil].
    Filosso PL
    Minerva Cardioangiol; 1996 Apr; 44(4):197-207. PubMed ID: 8767601
    [No Abstract]   [Full Text] [Related]  

  • 8. Antihypertensive mechanisms of beta-adrenoceptor blockade: a review.
    van Baak MA; Struyker Boudier HA; Smits JF
    Clin Exp Hypertens A; 1985; 7(1):1-72. PubMed ID: 2859936
    [No Abstract]   [Full Text] [Related]  

  • 9. [Hemodynamic modifications induced by urapidil in man].
    Bielen E; Fagard R; Lijnen P; M'Buyamba-Kabangu JR; Staessen J; Van Hoof R; Amery A
    Therapie; 1990; 45 Suppl 2():191-7. PubMed ID: 2187267
    [No Abstract]   [Full Text] [Related]  

  • 10. Nebivolol: a new beta blocker on the horizon.
    Katira R; Chauhan A
    Indian Heart J; 2000; 52(1):86-8. PubMed ID: 10820942
    [No Abstract]   [Full Text] [Related]  

  • 11. [Role of urapidil in the treatment of acute hypertension].
    Lehot JJ; Bonnefoy E; Dalmas JP; Filley S; Bastien O; George M
    Cah Anesthesiol; 1995; 43(1):67-76. PubMed ID: 7671060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical experience with prazosin hydrochloride in arterial hypertension.
    Turner AS; Watson O; Peel JS
    N Z Med J; 1975 Mar; 81(535):240-2. PubMed ID: 1055318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antihypertensive and hemodynamic properties of the new beta adrenergic blocking agent timolol.
    Franciosa JA; Freis ED; Conway J
    Circulation; 1973 Jul; 48(1):118-24. PubMed ID: 4150000
    [No Abstract]   [Full Text] [Related]  

  • 14. [Urapidil in primary arterial hypertension].
    Román O; Sudy E; Gac JC; Valenzuela MA
    Rev Med Chil; 1987 Jul; 115(7):648-54. PubMed ID: 3331026
    [No Abstract]   [Full Text] [Related]  

  • 15. Therapy with sildenafil or bosentan decreases pulmonary vascular resistance in patients ineligible for heart transplantation because of severe pulmonary hypertension.
    Perez-Villa F; Farrero M; Sionis A; Castel A; Roig E
    J Heart Lung Transplant; 2010 Jul; 29(7):817-8. PubMed ID: 20363156
    [No Abstract]   [Full Text] [Related]  

  • 16. A preliminary clinical trial of Prazosin: a new oral antihypertensive agent.
    Bolli P; Simpson FO
    N Z Med J; 1974 May; 79(516):969-72. PubMed ID: 4152750
    [No Abstract]   [Full Text] [Related]  

  • 17. [Hemodynamic changes and left ventricular function in patients with hypertension during an acute trial of urapidil].
    Sirakova V; Penkov N; Penev A
    Vutr Boles; 1988; 27(5):20-3. PubMed ID: 3062899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapy with hydrazinopyridazine, a new antihypertensive vasodilatory agent, in combination with beta-receptor blocking substances.
    Kirch W; von Gizycki C
    Int J Clin Pharmacol Ther Toxicol; 1980; 18(5):233-5. PubMed ID: 6104636
    [No Abstract]   [Full Text] [Related]  

  • 19. [Microcirculatory hemodynamic effects of Urapidil (Eupressyl)].
    Hamon P; Fossier JM; Macquin-Favier I; Maurel A; Lagrue G
    J Mal Vasc; 1991; 16(4):351-3. PubMed ID: 1791370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Beta-1 blockade plus NO release. Additional organ protection for patients with hypertension].
    MMW Fortschr Med; 2003 Oct; 145(40):57. PubMed ID: 14603611
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.